Ani pharmaceuticals announces fda approval of new purified cortrophin gel® prefilled syringe

Princeton, n.j., march 03, 2025 (globe newswire) -- ani pharmaceuticals, inc. (ani or the company) (nasdaq: anip) today announced u.s. food and drug administration (fda) approval of purified cortrophin® gel (repository corticotropin injection usp) (cortrophin gel) in a prefilled syringe format. this new presentation will be available in 40 usp units/0.5 ml and 80 usp units/ml single-dose options through cortrophin gel's established specialty pharmacy network. the prefilled syringe reduces administration steps for patients using cortrophin gel, which remains available in 5 ml and 1 ml vials. for full indications and important safety information, please see below.
ANIP Ratings Summary
ANIP Quant Ranking